Dr. Keller is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1575 Blondell Ave
Suite 125
Bronx, NY 10461Phone+1 718-405-8378Fax+1 718-405-8253
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Fellowship, Thoracic Surgery, 1985 - 1987
- Icahn School of Medicine at Mount SinaiResidency, Surgery, 1979 - 1985
- Zucker School of Medicine at Hofstra/NorthwellInternship, Internal Medicine, 1977 - 1978
- Albany Medical CollegeClass of 1977
Certifications & Licensure
- NY State Medical License 1978 - 2025
- PA State Medical License 1987 - 1994
- MD State Medical License 1982 - 1984
- American Board of Thoracic Surgery Thoracic and Cardiac Surgery
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2003-2014
- Top Doctors: New York Metro Area Castle Connolly, 2002-2014
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Join now to see all
Clinical Trials
- Erlotinib in Treating Patients With Stage I-IIIA Non-Small Cell Lung Cancer Undergoing Surgical Resection Start of enrollment: 2004 Dec 01
- A Phase II Study Of Imtox-25 In Adults With Refractory/Relapsed Cd25 Positive Adult T Cell Leukemia/Lymphoma Start of enrollment: 2010 Sep 01
- Azacitidine in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer Start of enrollment: 2015 Feb 09
Publications & Presentations
PubMed
- 2 citationsAnalysis of Outcomes With Addition of Immunotherapy to Chemoradiation Therapy for Non-Small Cell Lung Cancer-Reply.Salma K. Jabbour, Steven M. Keller, Martin Reck
JAMA Oncology. 2021-11-04 - 119 citationsPembrolizumab Plus Concurrent Chemoradiation Therapy in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer: The Phase 2 KEYNOTE-799 Non...Salma K. Jabbour, Ki Hyeong Lee, Nikolaj Frost, Valeriy Breder, Dariusz M. Kowalski
JAMA Oncology. 2021-06-04 - 6 citationsSmoking Behavior in Patients With Early-Stage NSCLC: A Report From ECOG-ACRIN 1505 Trial.Conor E. Steuer, Opeyemi Jegede, Suzanne E. Dahlberg, Heather A. Wakelee, Steven M. Keller
Journal of Thoracic Oncology. 2021-06-01
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: